Log in or Sign up for Free to view tailored content for your specialty!
Intervention News
Despite recommendations, ‘gap’ remains in inferior vena cava filter removal
Although the insertion of inferior vena cava filters declined between 2013 and 2021, the rate of retrievals remained low, according to a study published in JAMA.
In PCI for MI, spironolactone does not meet primary endpoints but may show benefit in HF
CHICAGO — In patients with acute MI who underwent PCI, spironolactone did not improve the primary composite outcomes but was linked to reduced risk for new or worsening HF, according to new data from the CLEAR SYNERGY (OASIS-9) trial.
Hearing, visual impairment tied to increased CVD risk among older Chinese population
Older Chinese adults with hearing, visual or dual sensory impairment had higher risk for CVD compared with those without sensory impairment, according to a study published in the Journal of the American Heart Association.
Log in or Sign up for Free to view tailored content for your specialty!
Cerebral embolic protection may help prevent stroke after TAVR, but data uncertain
WASHINGTON — In an exploratory analysis of the PROTECTED TAVR trial of patients undergoing transcatheter aortic valve replacement, cerebral embolic protection reduced risk for short-term stroke in patients from the U.S. but not elsewhere.
Clinician input essential in entire cardiology AI tool development process
Editor’s Note: This is part three of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy .
Bioadaptor may flatten event curve after PCI, including in complex lesions
WASHINGTON — A bioadaptor implant adaptable to vessel physiology was linked to fewer target lesion failure events after 6 months compared with a drug-eluting stent, including in high-risk lesions, researchers reported.
AI in cardiology: A call for robust validation, regulatory labeling and security of data
Editor’s Note: This is part two of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy.
Transcatheter tricuspid valve replacement effective treatment for severe regurgitation
In patients with severe tricuspid regurgitation, transcatheter tricuspid valve replacement plus medical therapy improved outcomes compared with medical therapy alone, researchers reported at TCT 2024.
TAVR could be ‘preferred therapeutic option’ over surgery for women
WASHINGTON — Women with symptomatic severe aortic stenosis had better 1-year outcomes after transcatheter aortic valve replacement vs. surgery, according to a pooled analysis of only women in the PARTNER 3 low-risk and RHEIA trials.
AI stands to change cardiology practice, but guidance, evidence of benefit are needed
Editor’s Note: This is part one of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy .
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read